Semaglutide API High Purity Peptide API Manufacturer Fast shipping %99 High Quality
TDS 414 Inquiries
910463-68-2
Pharmaceutical Grade
99%
Shang hai
Huaian Camelot Cosmetics Co., Ltd.
10 bottles per box
Yes
2026-12-02
Peptide
-
Product Details
-
Seller Information
-
Inquiry History
-
Description——Product Description——
Salesperson: Lris
whatsapp:+ 852 9179 4290
e-mail: 1532742904@qq.com
Company Profile
About Karom Peptide Co., Ltd.Karom Trading Firm located in China, we have years experience in chemical R&D and specializes in the R&D, production and sales of chemical raw materials, cosmetic additives, food additives and pharmaceutical raw materials to provide professional peptide product solutions to users. In the process of operation, it has gradually developed into a comprehensive enterprise integrating product customization, research and development, production and trade.
Tirzepatide Primary Efficacy (Phase III Clinical Data)
Mechanism of Action (Dual-Target)
1. **GLP-1 receptor**: Stimulates glucose-dependent insulin secretion, suppresses glucagon, delays gastric emptying, enhances satiety, reduces appetite, and promotes both blood glucose lowering and weight loss.
2. **GIP receptor**: Synergistically amplifies the glucose-lowering and weight-loss effects of GLP-1, improves pancreatic islet function, and enhances insulin sensitivity.Specification
Semaglutide
10mg\15mg\20mg\30mg
IntroductionProduct Detail
1. **Blood glucose lowering (glucose-dependent):** Promotes insulin secretion and inhibits glucagon release when blood glucose levels are high; the effect diminishes when blood glucose is within the normal range, resulting in a **very low risk of hypoglycemia when used as a monotherapy.**
2. **Appetite suppression and weight loss:** Acts on the appetite center in the hypothalamus to reduce hunger; also delays gastric emptying and increases satiety, leading to decreased food intake.3. **Cardiovascular protection:** Lowers the risk of myocardial infarction, stroke, and cardiovascular death in patients with type 2 diabetes who have coexisting cardiovascular disease; at doses used for weight loss, it also reduces the risk of major adverse cardiovascular events in individuals with obesity.4. **Renal benefits:** Reduces proteinuria and slows the progression of diabetic kidney disease.
Mechanism of action✅ Approved Indications
1. **Type 2 Diabetes**: Reduces glycated hemoglobin (HbA1c), fasting blood glucose, and postprandial blood glucose; provides protection for pancreatic β-cells.
2. **Long-term Weight Management (for Obesity/Overweight)**: Used in conjunction with diet and exercise; clinical trials show an average weight loss of approximately 21% at the 15 mg dosage.
3. **Moderate to Severe Obstructive Sleep Apnea (OSA) in Individuals with Obesity**: Improves symptoms of sleep apnea.
4. **Additional Benefits**: Improves blood pressure and lipid profiles; offers potential cardiovascular protective effects.
Frequently Asked Questions
Q1: Do you supply Semaglutide powder?Yes. SYNPEPTIDE supplies Semaglutide raw material powder for qualified B2B and research-related sourcing requirements, subject to availability and applicable requirements.
Q2: What is the purity of your Semaglutide?Purity specifications depend on the available batch. Please contact us for the current specification and batch-specific COA.
Q3: Can you provide a Semaglutide COA?Batch-specific COA and available analytical documentation can be provided upon request.
Q4: Can I purchase Semaglutide in bulk?Bulk inquiries are welcome. Please provide your required quantity so we can check availability and prepare a quotation.
Q5: What is your MOQ?MOQ depends on the current product and commercial requirements. Please contact us with your required quantity.
Q6: Can you provide samples?Sample availability depends on current inventory and commercial requirements. Please contact our sales team for details.
Q7: What packaging options are available?Packaging depends on the order quantity and product requirements. Please provide your required quantity and preferred packaging when requesting a quotation.
Q8: How can I get the latest Semaglutide price?Please send us your required quantity, destination, and specifications. We will provide the current quotation based on your purchasing requirements.
How to Request a Semaglutide Quotation
For a faster and more accurate quotation, please provide:
Required Semaglutide quantity
Required purity/specification
Destination country
Packaging requirements
Required quality documents
Expected purchasing schedule
Our sales team will review your requirements and provide the corresponding product information and quotation.
Quality Control
Quality is an important part of our peptide raw-material supply process.
Depending on the available batch and customer requirements, documentation may include:
Certificate of Analysis (COA)
HPLC analytical information
Product specifications
Batch information
Purity information
Other available analytical documentation
If your company has specific testing or documentation requirements, please provide them when sending your inquiry.
ECHEMI Editorial ReferenceSemaglutide (CAS: 910463‑68‑2) is a synthetic lipid‑modified peptide analogue, consisting of a 31‑amino‑acid backbone with a covalently attached C18 fatty di‑acid side‑chain via a hydrophilic spacer. It shares 94% amino‑acid sequence homology with native human GLP‑1 peptide. The substance appears as white to almost white hygroscopic powder, with molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and molecular weight of 4113.58 g/mol. Structural modifications grant it resistance against DPP‑4 enzymatic degradation and enable reversible binding to serum albumin, contributing to its extended in‑vivo half‑life property.
CertificatesBasic Info-
Product Name:
Semaglutide
Other Name:Sermaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;semaglutide;Sermaglutide CAS 910463 68 2;Semaglutide (H-7894.0001);semgalutide;Semaglutide
CAS No.:910463-68-2
Molecular Formula:C187H291N45O59
InChIKeys:DLSWIYLPEUIQAV-CCUURXOWSA-N
Molecular Weight:4113.57754
Exact Mass:4113.122087 g/mol
EC Number:203-405-2
Color/Form:White to off-white
Categories:
Characteristics-
PSA:
1650 Ų
XLogP3:5.44520
Critical Temperature & Pressure:Store at -20°C
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1 ; NEJM: Marso et al. (2016) — SUSTAIN-6 ; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide ; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
Reproductive toxicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H361 Suspected of damaging fertility or the unborn child
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptide
-
Location:
Room 107, Building A1, No. 66 Hechang Road
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
5 days
-
Year of Establishment:
2025
-
-
Inquiry History414 Inquiries
Country Product Purchase Quantity Date Posted
Nigeria
Semaglutide
20 MT Nov 5, 2026
United States
Semaglutide
5 PCS Nov 5, 2026
United States
Semaglutide
3 MT Nov 4, 2026
Italy
Semaglutide
10 MG Nov 3, 2026
Italy
Semaglutide
20 G Nov 3, 2026
Austria
CBL-514
500 MG Oct 28, 2026
United Kingdom
Semaglutide
1 G Oct 27, 2026
Belgium
Semaglutide
1 MT Oct 19, 2026
Chile
Semaglutide
10 MG Oct 16, 2026
Slovakia
semaglutide
10 MG Oct 15, 2026
Germany
Semaglutide
1 G Oct 14, 2026
South Africa
Semaglutide
10 MT Oct 11, 2026
United States
Semaglutide
1000 MT Oct 6, 2026
United States
Semaglutide
10 MT Sep 30, 2026
United States
Semaglutide
1000 KG Sep 30, 2026
United States
Semaglutide
30 MG Sep 28, 2026
United States
Semaglutide
10 MT Sep 25, 2026
Philippines
Semaglutide
10 MG Sep 20, 2026
India
Semaglutide
10 MG Sep 18, 2026
United Kingdom
Semaglutide - Reta - Tirz
100 MG Sep 17, 2026 Post an enquiry for this product
- Hot Searches
- polyurethane melting point
- chemical suppliers & distributors
- toronto chemical research
- sodium hydroxide price
- where can you buy aniracetam
- ambeed 87736-88-7 price
- anhydrous ammonia for sale
- sodium sulphate anhydrous price
- formaldehyde where to buy
- hexylene glycol sds
- emamectin benzoate for sale
- clind ph benzoyl perox
More from this Seller
-
-
-
Wholesale 99% high purity MS10 repair Lyophilized Peptide MOTS-c 10mg
High Purity Grade / 99%
$10/MT FOB
-
-
-
-
DSIP, Bioactive Peptide Compound for Signal Pathway Study
Pharmaceutical Grade / 99%
$65/UNIT FOB
-
-
-
-
Factory direct High Purity 99% skin tanning MT1 Melanotan
High Purity Grade / 99%
$10/MT FOB
-
-
-
-
CBL514 Peptide 5/10/15/25mg Factory Direct Supply Fast Delivery Research Grade
Research Grade / 99%
$6/UNIT FOB
-
-
-
-
High Purity Immune Modulating Peptide Advanced Thymosin Alpha-1
High Purity Grade / 99%
$10/MT FOB
-
-
-
-
Tirzepatide CAS 2023788-19-2 Purity 99 HPLC 5mg 10mg 15mg 20mg 30mg 40mg 50mg 60mg White Peptide Powder COA Provided
Pharmaceutical Grade / 99%
$20-26/UNIT FOB
-
